- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
RepliCel Life Sciences Inc (RP)RepliCel Life Sciences Inc stock price live, this page displays TSXV RP stock exchange data. View the RP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the RepliCel Life Sciences Inc real time stock price chart below.
What Is the RepliCel Life Sciences Inc Stock Price Today?
The RepliCel Life Sciences Inc stock price today is 0.0100.
What Is the Stock Symbol for RepliCel Life Sciences Inc?
The stock symbol for RepliCel Life Sciences Inc is "RP."
What Stock Exchange Does RepliCel Life Sciences Inc Trade On?
RepliCel Life Sciences Inc is listed and trades on the TSXV stock exchange.
Is RepliCel Life Sciences Inc a Good Stock to Buy?
Determining whether RepliCel Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RP quote. (ISIN: CA76027P4006)
What Is the RepliCel Life Sciences Inc Stock Price Today?
The RepliCel Life Sciences Inc stock price today is 0.0100.
What Is the Stock Symbol for RepliCel Life Sciences Inc?
The stock symbol for RepliCel Life Sciences Inc is "RP."
What Stock Exchange Does RepliCel Life Sciences Inc Trade On?
RepliCel Life Sciences Inc is listed and trades on the TSXV stock exchange.
Is RepliCel Life Sciences Inc a Good Stock to Buy?
Determining whether RepliCel Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RP quote. (ISIN: CA76027P4006)
0.0100
0.0000(0.00%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0100
0.0150
52 wk Range
0.0100
0.0950
RP Scorecard
Full Analysis
Net income is expected to grow this year
Trading near 52-week Low
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.01000.0150
52 wk Range
0.01000.0950
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockRP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
RepliCel Life Sciences Inc Company Profile
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy to treat tendon injuries, androgenetic alopecia, and skin aging by restoring cellular function to rejuvenate aging or sun damaged skin, regrow hair, and repair tendons. The company’s product candidates include RCH-01, a cell therapy for pattern baldness; RCS-01, a cell therapy foraging or sun damaged skin; and RCT-01, a cell therapy for tendon degeneration. It is also developing DermaPrecise, a dermal injection device. The company has a licensing and collaborative agreement with YOFOTO (China) Health Industry Co. Ltd. to develop and commercialize RCS-01, RCT-01, and DermaPrecise. RepliCel Life Sciences Inc. is based in Vancouver, Canada.
Compare RP to Peers and Sector
Metrics to compare | RP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.1x | −3.3x | −0.7x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | 0.0x | 0.2x | 2.6x | |
Price / LTM Sales | 0.5x | 4.7x | 3.2x | |
Upside (Analyst Target) | - | 107.9% | 44.1% | |
Fair Value Upside | Unlock | −2.1% | 8.2% | Unlock |
FAQ
What Is the RepliCel Life Sciences (RP) Stock Price Today?
The RepliCel Life Sciences stock price today is 0.01
What Stock Exchange Does RepliCel Life Sciences Trade On?
RepliCel Life Sciences is listed and trades on the TSXV stock exchange.
What Is the Stock Symbol for RepliCel Life Sciences?
The stock symbol for RepliCel Life Sciences is "RP."
What Is the RepliCel Life Sciences Market Cap?
As of today, RepliCel Life Sciences market cap is 650.02K.
What is RepliCel Life Sciences Earnings Per Share?
The RepliCel Life Sciences EPS is 0.019.
From a Technical Analysis Perspective, Is RP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.